Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-07-08
1998-07-14
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514422, A61K 3135, A61K 3140
Patent
active
057805024
ABSTRACT:
The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, C.sub.1-6 alkyl, C.sub.1-6 alkoxy or (tertiary amino)( C.sub.1-6 alkoxy); and R.sup.2 and R.sup.3 are individually hydrogen or C.sub.1-6 alkyl, or a pharmaceutically acceptable salt thereof for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome.
REFERENCES:
patent: 3822287 (1974-07-01), Bolger
patent: 4447622 (1984-05-01), Salman et al.
patent: 5280040 (1994-01-01), Labroo et al.
patent: 5453442 (1995-09-01), Bryant et al.
Joseph F. Mortola, M.D., "Pathophysiology and Treatment of Premenstrual Syndrome", 1995 Rapid Science Publishers ISSN 1068-3097, pp. 483-492.
Gregg Valeta
Henley III Raymond
Novo Nordisk A S
Zelson Steve T.
LandOfFree
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceut does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 3,4-diphenyl chromans for the manufacture of a pharmaceut, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 3,4-diphenyl chromans for the manufacture of a pharmaceut will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1882199